343 results
8-K
EX-1.1
MEIP
MEI Pharma Inc
21 Feb 24
Other Events
4:00pm
not be required to specify the nature of such proposed transaction), (A) offer, pledge, announce the intention to sell, sell, contract to sell, sell any … . The Company agrees that it will not claim that the Agent has rendered advisory services of any nature or
respect, or owes a fiduciary or similar duty
8-K
EX-99.1
MEIP
MEI Pharma Inc
13 Feb 24
MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights
5:05pm
Statements
Certain information contained in this press release that are not historical in nature are “forward-looking statements” within the meaning
8-K
EX-99.1
jcblac
11 Dec 23
MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023
4:00pm
8-K
EX-99.1
86kd8
9 Nov 23
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
4:06pm
DFAN14A
pr4oqq01zq8cizwn
1 Nov 23
Additional proxy materials by non-management
5:15pm
DEFA14A
gxnkv5n8ht vstp
1 Nov 23
Additional proxy soliciting materials
4:54pm
8-K
EX-10.1
s8u73zsxlb
1 Nov 23
MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital
4:01pm
8-K
EX-99.1
8j6d9 7gzgml2ay24
1 Nov 23
MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital
4:01pm
DEFA14A
tu64p
18 Oct 23
Additional proxy soliciting materials
12:00am
DEFC14A
tno3sl29p py4
17 Oct 23
Proxy in contested solicitation
5:28pm
DEFC14A
a4qram717i4 4b2uia
10 Oct 23
Proxy in contested solicitation
10:33am
8-K
EX-99.1
c2uts9jpuu3
3 Oct 23
Entry into a Material Definitive Agreement
6:04am
8-K
EX-4.1
83s4jrzi4kvoidq
3 Oct 23
Entry into a Material Definitive Agreement
6:04am